Texas Investors Saddle Up and Ride Into San Francisco’s Real Estate Bargain Boom

Texas-themed illustration

San Francisco’s commercial real estate market has a new sheriff in town—and they’re wearing cowboy boots. Investors from Texas are riding into downtown properties, snapping up buildings at prices the city hasn’t witnessed in decades. From Union Square to California Street, Lone Star capital is giving new life to a market many thought was on life support.

One of the most talked‑about grabs is the seven‑story One Union Square building at Geary and Stockton, which recently slipped into foreclosure. The Standard reports that Texans have been among the most enthusiastic bidders eyeing distressed assets across the district.

Lone Star Funds Rides Into Town

Texas-based Lone Star Funds has quietly emerged as the likely buyer for the 360,000‑square‑foot tower at 600 California Street—formerly a flagship WeWork location. Though the Dallas investment group remains tight‑lipped, industry insiders claim a deal is fast approaching. More details surfaced from BizJournals.

Related Market Moves

Other major players are saddling up as well—from bidders circling the long‑struggling Oceanwide Center to Goodwill of Silicon Valley stepping unexpectedly into office‑landlord territory. Check out these stories:

Downtown’s $1.6B ‘money pit’ is close to getting scooped up

Your favorite thrift store just became a San Jose office landlord

This arts nonprofit lost venues—so it opened its own

Why Everyone Suddenly Wants SF Again

According to Derek Daniels, research director at Colliers, San Francisco’s “boom loop” recovery narrative is gaining traction. Outside investors—especially from Texas—see a city poised for a rebound rather than another slide.

He credits Mayor Daniel Lurie for helping restore investor confidence by amplifying the city’s recovery story nationwide. And confidence, as we know, is worth its weight in gold—or in this case, square footage.

Union Square: The Comeback Kid

Kelly Glass, principal at Avison Young, says out‑of‑state investors are increasingly energized by new leasing momentum throughout Union Square. “There’s a new investor pool focused on the area,” she shared. “Whenever I speak to them, they’re like, ‘Oh, you’re getting us excited,’ because the volume is there.”

That excitement is matched by investors not only from Texas, but New York, Alaska, and Southern California. Uris Acquisitions—rooted deeply in NY real estate—has scooped up three Powell Street buildings since May alone.

Have We Hit the Bottom?

Lacie Ravina, vice president at Colliers, believes the answer is clear: yes. “I think it signifies that we’ve bottomed out, and investors have realized that it’s time to acquire buildings at historic lows,” she explained. With inquiries pouring in and momentum building, she expects the trend to continue well into next year.

For real estate professionals—whether working in California, Texas, or right here in Florida—this moment is a reminder that market cycles always turn. And for students strengthening their skills or adding new licenses, programs through Cameron Academy help professionals stay competitive as markets shift nationwide.

Source reporting courtesy of The San Francisco Standard.

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Remote Work Revolution: Redefining Real Estate

Imagine a morning where the commute is just a few steps from your bedroom to your home office. This is the reality for many in today's post-pandemic world, where remote work has become a staple of the modern workforce.

By |December 2, 2024|Categories: Article, Real Estate, Remote Work|Tags: , |0 Comments

CRISPR: The Future of Gene Editing and Its Clinical Implications

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.

By |December 1, 2024|Categories: Article, Biotechnology, Medicine|Tags: , |0 Comments

AI Revolution in Oncology: Transformative Potential or Overhyped?

In recent years, artificial intelligence has emerged as a revolutionary tool in the field of oncology. AI's integration into healthcare transcends buzzwords, transforming cancer diagnosis, treatment personalization, and drug discovery.

AI in Radiology: A Double-Edged Sword

The rapid advancements in artificial intelligence (AI) are transforming the landscape of radiology, promising to enhance diagnostic accuracy and support personalized medicine. However, as this technology becomes more integral to medical imaging, it brings with it a host of ethical and societal considerations that cannot be ignored.

Humanity at the Crossroads: Ethical Implications of AI in Medicine

AI's promise in healthcare is undeniable, with its ability to uncover hidden disease patterns and predict illnesses. However, the reliance on historical data can exacerbate existing biases, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic and racial groups.

The Future of Telemedicine: Challenges and Opportunities Beyond the Pandemic

Telemedicine stands out as a transformative force, offering a lifeline to patients and providers alike. As we move beyond the pandemic, the challenge is to integrate this technology without escalating costs or overshadowing the indispensable role of in-person consultations.

By |November 30, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments